MedTrace Logo

Algorithms to Diagnose Pulmonary Arterial Hypertension

NCT05417373 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-06-14

No results posted yet for this study

Summary

The investigators intend to evalute the value of radiomics signature of pulmonary vessels from chest computed tomography (CT) for dianosis and prognosis of pulmonary arterial hypertension.

Conditions

Interventions

OTHER

calculated radscore

The development cohort is case\_control research. The validation cohort is prospective study to test the accuracy of calculated radscore based on diagonisis model.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER

  • Xinqiao Hospital of Chongqing

    collaborator OTHER

  • Shanghai Pulmonary Hospital, Shanghai, China

    collaborator OTHER

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Jieyan Shen, PhD · Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-17
Primary Completion
2022-12-01
Completion
2023-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05417373 on ClinicalTrials.gov